期刊文献+

Preparation of protein-loaded microspheres with size ≤ 10 μm by electrostatic droplet generation technology 被引量:3

Preparation of protein-loaded microspheres with size≤10 μm by electrostatic droplet generation technology
原文传递
导出
摘要 The development of non-injection route for protein drugs, especially oral administration, has been the main focus of controlled release of drugs. To overcome obstacles unsolved such as enzyme degradation and penetration barrier of intestinal epi- thelium, technologies using microspheres as carrier of protein drugs have been proven potential to realize oral administration. It has been demonstrated that microspheres can not only protect proteins, but also facilitate the penetration and absorption through Peyer’s patches when the size is smaller than 10 μm. Therefore, the objective of this paper is to prepare protein-loaded microspheres with size ≤ 10 μm. Electrostatic droplet generation technology was used with insulin and hemoglobin as drug models and so- dium alginate as microsphere material. By decreas- ing the surface tension of feed solution by adding surfactant, and improving electric field distribution by changing the shape of container and electrode for gelation solution, protein-loaded microspheres with mean size less than 10 μm were successfully pro- duced through needle with diameter of 400 μm. The microspheres showed good sphericity and narrow size distribution. The mean standard variance of size distribution was 1.61. The encapsulation efficiency of proteins was over 70%. Moreover, the significance analysis of factors influencing the size of protein loaded microspheres was carried out through or- thogonal experiments, which showed that output voltage (U), needle diameter (D) and the distance between needle tips to the surface of gelation solu- tion (δ ) influenced significantly the size of micro-spheres. Finally, the statistic analysis showed that when confidence level was α=0.05, and α=0.1, con- fidence interval of microsphere size can be (6.2545, 10.1735) and (6.6022, 9.8258) correspondingly, suggesting that there is good repeatability and reli- ability for improving electrostatic droplet generation technology to prepare protein-loaded microspheres with size ≤10 μm. The development of non-injection route for protein drugs, especially oral administration, has been the main focus of controlled release of drugs. To overcome obstacles unsolved such as enzyme degradation and penetration barrier of intestinal epithelium, technologies using microspheres as carrier of protein drugs have been proven potential to realize oral administration. It has been demonstrated that microspheres can not only protect proteins, but also facilitate the penetration and absorption through Peyer's patches when the size is smaller than 10 μm. Therefore, the objective of this paper is to prepare protein-loaded microspheres with size ≤ 10 μm. Electrostatic droplet generation technology was used with insulin and hemoglobin as drug models and sodium alginate as microsphere material. By decreasing the surface tension of feed solution by adding surfactant, and improving electric field distribution by changing the shape of container and electrode for gelation solution, protein-loaded microspheres with mean size less than 10 μm were successfully produced through needle with diameter of 400 μm. The microspheres showed good sphericity and narrow size distribution. The mean standard variance of size distribution was 1.61. The encapsulation efficiency of proteins was over 70%. Moreover, the significance analysis of factors influencing the size of protein loaded microspheres was carried out through orthogonal experiments, which showed that output voltage (U), needle diameter (D) and the distance between needle tips to the surface of gelation solution (8) influenced significantly the size of microspheres. Finally, the statistic analysis showed that when confidence level was α=0.05, and α=0.1, confidence interval of microsphere size can be (6.2545, 10.1735) and (6.6022, 9.8258) correspondingly, suggesting that there is good repeatability and reliability for improving electrostatic droplet generation technology to prepare protein-loaded microspheres with size ≤ 10 μm.
出处 《Chinese Science Bulletin》 SCIE EI CAS 2006年第3期279-286,共8页
基金 This work was supported by the National Natural Science Foundation of China (Grant Nos. 50373046 and 20176056).
关键词 胰岛素 血色素 藻酸盐 蛋白质微球 微囊化 静电液滴发电技术 electrostatic droplet generation technology, insulin, hemoglobin, alginate, microsphere, size, encapsulation efficiency.
  • 相关文献

同被引文献22

  • 1薛伟明,于炜婷,刘袖洞,贺欣,王为,马小军.载细胞海藻酸钠/壳聚糖微胶囊的化学破囊方法研究[J].高等学校化学学报,2004,25(7):1342-1346. 被引量:63
  • 2吴顺芹,李三鸣,郎轶咏,刘华,刘洪卓.水包油型微乳形成因素的考察[J].沈阳药科大学学报,2005,22(2):96-99. 被引量:21
  • 3袁悦,李英,李三鸣.注射用环孢素A亚微乳的制备[J].中国新药杂志,2006,15(12):982-985. 被引量:9
  • 4梁志波,李小飞,刘锟,吴红,赵晋波.局部应用环孢素A聚乳酸微球的性状及释药研究[J].中国药物与临床,2007,7(1):9-12. 被引量:6
  • 5林志共 刘群丽 郭红 等.小鼠血糖法测定胰岛素生物效价的探讨——用葡萄糖氧化酶法测定小鼠血糖值[J].药物分析杂志,1985,5(6):333-334.
  • 6Gerardo P Carino, Edith Matiowitz. Oral insulin delivery[ J].Advanced Drug Delivery Reviews,1999,35 : 249-257.
  • 7Gerardo P Carino, Jules S Jacob, Edith Mathiowitz. Nanosphere based oral insulin delivery [ J ]. Journal of Controlled Release,2000, 65 : 261-269.
  • 8Modi P, Mihic M. Replacement of s. c injections with oralin in treatment of diabetes [ J ]. Diabetes,2001,50 (12) : A44-A44.
  • 9Christians U.Transport proteins and intestinal metabolism; P-glycoproteinand cytochrome P4503A.. Therapeutic Drug Monitoring . 2009
  • 10Hirunpanich V,KatagiJ,Sethabouppha B,et al.Demonstration of docosahexaenoic acid as a bioavailability enhancer for CYP3A substrates:in vitro and in vivo evidence using cyclosporin in rats. Drug Metab.Dispos . 2008

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部